Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Chengdu Kanghua Biological Products Co.
AddedFeb 13, 2024
UpdatedJun 28, 2026
Chengdu Kanghua Biological Products Co.

Chengdu Kanghua Biological Products Co.

Chengdu Kanghua, a leading Chinese manufacturer, specializes in researching, producing, and distributing vaccines.

HQ
Chengdu, Sichuan, CN
Founded
2004
Overview
Compare
Employees

Chengdu Kanghua Biological Products Co., Ltd. is a leading Chinese manufacturer specializing in researching, producing, and distributing vaccines. The company offers a range of products, including rabies vaccines and meningococcal polysaccharide vaccines, primarily targeting the Chinese market.

Chengdu Kanghua has made significant strides in the vaccine industry, contributing to public health through its high-quality products. Its impact is notable in the prevention of infectious diseases in China. The company is recognized for its commitment to innovation and quality in vaccine production.

Similar Companies

Walvax Biotechnology Co. logo

Walvax Biotechnology Co.

walvax.com

Sinovac Biotech logo

Sinovac Biotech

Shanghai Kehua Bio-Engineering Co. logo

Shanghai Kehua Bio-Engineering Co.

3SBio logo

3SBio

Harbin Gloria Pharmaceuticals Co. logo

Harbin Gloria Pharmaceuticals Co.

Sino Biopharmaceutical logo

Sino Biopharmaceutical

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

Jianmin Pharmaceutical Group Co logo

Jianmin Pharmaceutical Group Co

China PharmaHub logo

China PharmaHub

Innovent Biologics logo

Innovent Biologics

FruitVaccine logo

FruitVaccine

fruitvaccine.org

Dong-A ST Co. logo

Dong-A ST Co.

Huadong Medicine logo

Huadong Medicine

SK Bioscience logo

SK Bioscience

skbioscience.co.kr

Livzon Mabpharm logo

Livzon Mabpharm

Chengdu Kanghua Biological Products Co. - Quick Facts

Who are Chengdu Kanghua Biological Products Co.'s competitors?

Companies similar to Chengdu Kanghua Biological Products Co. include Walvax Biotechnology Co., Sinovac Biotech, Shanghai Kehua Bio-Engineering Co. and 3SBio.

When was Chengdu Kanghua Biological Products Co. founded?

Chengdu Kanghua Biological Products Co. was founded in 2004.

Where is Chengdu Kanghua Biological Products Co.'s headquarters located?

Chengdu Kanghua Biological Products Co.'s headquarters is located in Chengdu, Sichuan, CN.

How many employees does Chengdu Kanghua Biological Products Co. have?

Chengdu Kanghua Biological Products Co. has 673 employees as of Feb 6, 2024.

Classification

Ownership
  • Private
Technology
  • Biotech
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Vaccines
Tags
  • Distribution
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations